Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Communicative & Integrative Biology|November 23, 2013
RIN1 regulates cell migration through RAB5 GTPases and ABL tyrosine kinasesKavitha Balaji, John Colicelli
British Journal of Cancer|January 11, 2017
Giving AXL the axe: targeting AXL in human malignancyCarl M Gay, Kavitha Balaji, Lauren Averett Byers
Traffic (Copenhagen, Denmark)|August 2, 2014
The RAB5-GEF function of RIN1 regulates multiple steps during Listeria monocytogenes infectionKavitha Balaji, Christopher T French, Jeff F Miller, et al.
BMJ Open|November 4, 2015
'The phone reminder is important, but will others get to know about my illness?' Patient perceptions of an mHealth antiretroviral treatment support intervention in the HIVIND trial in South IndiaRashmi Rodrigues, S Poongulali, Kavitha Balaji, et al.
Journal of Cell Science|September 15, 2012
RIN1 orchestrates the activation of RAB5 GTPases and ABL tyrosine kinases to determine the fate of EGFRKavitha Balaji, Chelsea Mooser, Christine M Janson, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|August 27, 2019
Work productivity burden and indirect costs associated with carcinoid syndrome diarrheaArvind Dasari, Vijay N Joish, Raul Perez-Olle, et al.
World Journal of Gastroenterology|December 31, 2019
Direct costs of carcinoid syndrome diarrhea among adults in the United StatesArvind Dasari, Vijay N Joish, Raul Perez-Olle, et al.
AIDS and Behavior|January 7, 2010
Adherence to antiretroviral therapy in patients participating in a graduated cost recovery program at an HIV care center in South IndiaAshita S Batavia, Kavitha Balaji, Elizabeth Houle, et al.
The Indian Journal of Medical Research|July 16, 2013
Immunologic response among HIV-infected patients enrolled in a graduated cost-recovery programme of antiretroviral therapy delivery in Chennai, IndiaSunil Suhas Solomon, Aylur K Ganesh, Shruti H Mehta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2018
Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric CancerFunda Meric-Bernstam, Amber M Johnson, Ecaterina E Ileana Dumbrava, et al.
Pageof 2